Lothar Burghaus

2.2k total citations
61 papers, 1.5k citations indexed

About

Lothar Burghaus is a scholar working on Neurology, Psychiatry and Mental health and Cellular and Molecular Neuroscience. According to data from OpenAlex, Lothar Burghaus has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Neurology, 16 papers in Psychiatry and Mental health and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in Lothar Burghaus's work include Epilepsy research and treatment (13 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Neurological disorders and treatments (8 papers). Lothar Burghaus is often cited by papers focused on Epilepsy research and treatment (13 papers), Parkinson's Disease Mechanisms and Treatments (10 papers) and Neurological disorders and treatments (8 papers). Lothar Burghaus collaborates with scholars based in Germany, United States and United Kingdom. Lothar Burghaus's co-authors include Karl Herholz, Gereon R. Fink, S. Weisenbach, Elke Kalbe, R. Hilker, Ulrich Schütz, Norbert Galldiks, Jon Lindstrom, Hannsjörg Schröder and Heiss Wd and has published in prestigious journals such as Neurology, Journal of Cerebral Blood Flow & Metabolism and Movement Disorders.

In The Last Decade

Lothar Burghaus

55 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lothar Burghaus Germany 20 707 385 292 258 200 61 1.5k
O.J.M. Vogels Netherlands 23 652 0.9× 504 1.3× 317 1.1× 166 0.6× 504 2.5× 42 1.8k
Wei Song China 25 1.2k 1.7× 388 1.0× 645 2.2× 290 1.1× 279 1.4× 106 2.1k
C A Bloxham United Kingdom 17 615 0.9× 346 0.9× 221 0.8× 450 1.7× 215 1.1× 33 1.6k
Francesco Roselli Germany 25 851 1.2× 664 1.7× 649 2.2× 182 0.7× 585 2.9× 78 2.2k
Daniel Bittner Germany 22 531 0.8× 113 0.3× 207 0.7× 233 0.9× 372 1.9× 39 1.2k
Witold Libionka Poland 12 382 0.5× 591 1.5× 257 0.9× 180 0.7× 191 1.0× 34 1.5k
Bert Bosche Germany 21 572 0.8× 298 0.8× 245 0.8× 149 0.6× 115 0.6× 38 1.3k
K Krampfl Germany 16 826 1.2× 400 1.0× 384 1.3× 124 0.5× 105 0.5× 32 1.3k
Anna M. Karydas United States 18 733 1.0× 378 1.0× 514 1.8× 347 1.3× 849 4.2× 24 1.9k
Tatsuhiro Terada Japan 20 326 0.5× 216 0.6× 332 1.1× 131 0.5× 332 1.7× 55 1.2k

Countries citing papers authored by Lothar Burghaus

Since Specialization
Citations

This map shows the geographic impact of Lothar Burghaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lothar Burghaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lothar Burghaus more than expected).

Fields of papers citing papers by Lothar Burghaus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lothar Burghaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lothar Burghaus. The network helps show where Lothar Burghaus may publish in the future.

Co-authorship network of co-authors of Lothar Burghaus

This figure shows the co-authorship network connecting the top 25 collaborators of Lothar Burghaus. A scholar is included among the top collaborators of Lothar Burghaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lothar Burghaus. Lothar Burghaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Burghaus, Lothar, et al.. (2023). Prehospital Levetiracetam Use in Adults With Status Epilepticus: Results of a Multicenter Registry. Journal of Clinical Neurology. 19(4). 365–365. 1 indexed citations
3.
Lang, Nicolas, Max Lange, Friedhelm C. Schmitt, et al.. (2016). Intravenous lacosamide in clinical practice–Results from an independent registry. Seizure. 39. 5–9. 21 indexed citations
4.
Lang, Nicolas, Stefan Evers, Christoph Kellinghaus, et al.. (2015). Intravenous levetiracetam in clinical practice – Results from an independent registry. Seizure. 29. 109–113. 6 indexed citations
5.
Stetefeld, Henning, Helmar C. Lehmann, Gereon R. Fink, & Lothar Burghaus. (2014). Posterior Reversible Encephalopathy Syndrome and Stroke after Intravenous Immunoglobulin Treatment in Miller–Fisher Syndrome/Bickerstaff Brain Stem Encephalitis Overlap Syndrome. Journal of Stroke and Cerebrovascular Diseases. 23(9). e423–e425. 22 indexed citations
6.
Lie, Chuh‐Hyoun, et al.. (2011). Perfusion computer tomography helps to differentiate seizure and stroke in acute setting. Clinical Neurology and Neurosurgery. 113(10). 925–927. 14 indexed citations
7.
Galldiks, Norbert, Lothar Burghaus, Christian Dohmen, et al.. (2011). Immunoadsorption in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy with Unsatisfactory Response to First-Line Treatment. European Neurology. 66(4). 183–189. 30 indexed citations
8.
Burghaus, Lothar, Carsten Eggers, Lars Timmermann, Gereon R. Fink, & Nico J. Diederich. (2011). Hallucinations in Neurodegenerative Diseases. CNS Neuroscience & Therapeutics. 18(2). 149–159. 49 indexed citations
9.
10.
Eggers, Carsten, Lothar Burghaus, Gereon R. Fink, & Christian Dohmen. (2009). Epilepsia partialis continua responsive to intravenous levetiracetam. Seizure. 18(10). 716–718. 10 indexed citations
11.
Florin, Esther, Christiane Reck, Lothar Burghaus, et al.. (2008). Ten Hertz thalamus stimulation increases tremor activity in the subthalamic nucleus in a patient with Parkinson’s disease. Clinical Neurophysiology. 119(9). 2098–2103. 23 indexed citations
12.
Burghaus, Lothar, et al.. (2007). Acute Loss of Vision With Hypoplasia of the Contralateral Carotid Artery. Journal of Stroke and Cerebrovascular Diseases. 16(1). 43–44. 3 indexed citations
13.
Galldiks, Norbert, Lutz Kracht, Lothar Burghaus, et al.. (2006). Use of 11C-methionine PET to monitor the effects of temozolomide chemotherapy in malignant gliomas. European Journal of Nuclear Medicine and Molecular Imaging. 33(5). 516–524. 89 indexed citations
14.
Hilker, Ruediger, et al.. (2006). Functional brain imaging in combined motor and sleep disorders. Journal of the Neurological Sciences. 248(1-2). 223–226. 16 indexed citations
15.
Burghaus, Lothar, et al.. (2005). Glykogenose Typ II (M. Pompe). Der Nervenarzt. 77(2). 181–186. 12 indexed citations
16.
Hilker, R., Aline Thomas, Johannes Klein, et al.. (2005). Dementia in Parkinson disease. Neurology. 65(11). 1716–1722. 280 indexed citations
17.
Burghaus, Lothar, et al.. (2003). Loss of nicotinic acetylcholine receptor subunits α4 and α7 in the cerebral cortex of Parkinson patients. Parkinsonism & Related Disorders. 9(5). 243–246. 46 indexed citations
18.
Schröder, Hannsjörg, Ulrich Schütz, Lothar Burghaus, et al.. (2001). Expression of the α4 isoform of the nicotinic acetylcholine receptor in the fetal human cerebral cortex. Developmental Brain Research. 132(1). 33–45. 9 indexed citations
19.
Burghaus, Lothar, et al.. (2001). Nucleus basalis Meynert lesions and the expression of nicotinic acetylcholine receptor proteins in the rat frontal cerebral cortex. Neuroscience Letters. 301(2). 111–114. 2 indexed citations
20.
Burghaus, Lothar, Ulrich Schütz, Rob A. I. de Vos, et al.. (2000). Quantitative assessment of nicotinic acetylcholine receptor proteins in the cerebral cortex of Alzheimer patients. Molecular Brain Research. 76(2). 385–388. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by O.J.M. Vogels Breakdown of academic impact, for papers by Wei Song Breakdown of academic impact, for papers by C A Bloxham Breakdown of academic impact, for papers by Francesco Roselli Breakdown of academic impact, for papers by Daniel Bittner Breakdown of academic impact, for papers by Witold Libionka Breakdown of academic impact, for papers by Bert Bosche Breakdown of academic impact, for papers by K Krampfl Breakdown of academic impact, for papers by Anna M. Karydas Breakdown of academic impact, for papers by Tatsuhiro Terada
Rankless by CCL
2026